Atlas FDA

K-ASSAY IgA Immunoturbidimetric Assay, REF: KAI-013

FDA device recall Z-0271-2023 · posted 2022-11-21 · Open, Classified

Recall details

Recalling firm
Kamiya Biomedical Company, LLC
Reason for recall
IgA Reagent may start showing cloudiness over time, which can affect assay performance.
Action taken
On 9/28/22, recall notices were sent to customers informing them to stop using affected kit lots and to return complete and partially used kits to the recalling firm. Further, if opaque turbidity is observed, or the controls of the affected assay are not within range, do not report the test results. Distributors are asked to contact their customers and to inform them of the recall. Alternately, distributors can send the recalling firm their customer list so the recalling firm can notify the customers directly. Complete and return the customer acknowledgement. The following firm contacts were provided: (206) 575-8068 and quality@k-assay.com
Root cause
Under Investigation by firm
Status
Open, Classified
Product code
CFF
Quantity affected
165
Distribution
Worldwide - US Nationwide distribution in the states of FL, NC, TX, TN, PA, CA, NY, IL, MA and the country of Czech Republic.
Date initiated
2022-09-28
Date posted
2022-11-21
Location
Tukwila, WA

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
K-ASSAY IGA (K993213)Kamiya Biomedical Co.1999-11-23